Pedro Ernesto University Hospital
Rio de Janeiro, 20551-030, Brazil
Location status: Recruiting
NCT Number: NCT07191743
This longitudinal, prospective observational study aims to evaluate functional status in critically ill adult patients in the Intensive Care Unit using the Chelsea Critical Care Physical Assessment Tool (CPAx). The primary objective is to analyze CPAx score variation as a potential predictor of clinical outcomes, including mortality and duration of mechanical ventilation. Functional assessments will be performed at intensive care unit (ICU) admission and discharge to monitor changes in physical function and to predict adverse clinical outcomes.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Rio de Janeiro, 20551-030, Brazil
Location status: Recruiting
This prospective, longitudinal, and observational study will be conducted at the general ICU of Pedro Ernesto University Hospital (HUPE). Demographic and clinical information at admission will be collected, including age, sex, type of airway at ICU admission, cause of ICU admission, comorbidities, and clinical scores such as Sepsis-related Organ Failure Assessment (SOFA), Simplified Acute Physiology Score III (SAPS III), and Charlson Comorbidity Index. During the ICU stay, data on the use of invasive mechanical ventilation, non-invasive ventilation, high-flow nasal cannula (HFNC), renal replacement therapy, extubation, and reintubation will be recorded. The CPAx will be assessed at ICU admission and discharge. Additionally, total hospital and ICU length of stay, as well as days on mechanical ventilation, will be recorded.The study aims to analyze the variation in CPAx scores as a predictor of adverse clinical outcomes, including mortality and duration of mechanical ventilation.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
All adult patients admitted to the Pedro Ernesto University Hospital (HUPE) General ICU over 18 years of age and with an ICU stay greater than or equal to 48 hours will be included.
Exclusion criteria
Time frame: 12 months
Mortality will be collected during the period of hospitalization
Time frame: 6 months
It will be collected from the date of intubation in the intensive care unit until the date of extubation or up to 48 hours off mechanical ventilation in cases of tracheostomized patients and/or until the outcome of death
Time frame: 6 months
It will be collected from the date of intensive care unit admission until the outcome of discharge from the intensive care unit or death.
Time frame: 12 months
It will be collected from the date of intensive care unit admission until the outcome of hospital discharge or death.
Time frame: 30 days
Proportion of patients who were extubated during ICU stay.
Time frame: 30 days
Proportion of patients who require reintubation after extubation during ICU stay.
Contact information is provided by the study sponsor or research team.
GABRIEL G MAIA, PhD
CONTACT
RAFAELA S PAIM
CONTACT
Universidade Federal do Rio de Janeiro
Other
Assessment of Physical Function in Critically Ill Patients With the Chelsea Critical Care Assessment Tool (CPAX)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06653998
Intensive Care Unit Acquired Weakness, Intensive Care Unit Patients
Bogotá, Bogota D.C., Colombia
View Trial DetailsNCT07069959
Intensive Care Unit Acquired Weakness, Muscle Weakness
Nantes, Loire Atlantique, France
View Trial DetailsNCT05279547
Critical Illness, Disease Attributes
Leuven, Belgium
View Trial DetailsNCT04989790
Child, Confusion
Madera, California, United States
View Trial Details